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Survey of Provider Information Needs
Healthy People 2020 includes three developmental objectives related to sickle cell disease (SCD) that Georgia’s Public 
Health Research, Epidemiology, and Surveillance in Hemoglobinopathies (PHRESH) project seeks to address. These are to 
increase the proportion of persons with hemoglobinopathies who receive 1) appropriate immunizations (BDBS-1), 2) early 
and continuous screening (BDBS-4), and 3) disease-modifying therapies (BDBS-5). In order to inform health promotion 
efforts in these areas, we conducted a survey to assess medical providers’ needs for educational materials on appropriate 
immunizations, the use of a chemotherapy medication named hydroxyurea as a disease-modifying therapy, and the need 
for early  and annual Trans-Cranial Doppler (TCD) screening to identify stroke risk in children starting at age two. This 
brief describes the survey population and responses, and discusses possible implications of the results.
Survey Population 
During the month of August 2013, the Sickle Cell Foundation of Georgia, Inc. (SCFG) and the Georgia Department of 
Public Health (GDPH) conducted scripted telephone interviews with provider representatives across the state and recorded 
responses in a standardized log. We targeted pediatric and family practices because surveillance through the Registry and 
Surveillance System for Hemoglobinopathies (RuSH) project indicated that sickle cell patients in Georgia have most of 
their medical provider interactions with pediatricians, family physicians, and other health care providers.  
Surveys were completed with 100 practices in 48 counties that, according to RuSH data, contain 85 percent of all confirmed 
SCD cases in Georgia. The large majority of respondents represented pediatric-only practices. The remainder included 
family physicians, clinics, health departments, and Federally Qualified Health Centers. Forty-five of the practices reported 
serving mainly black patient populations; 10 served black and one other race/ethnicity; 10 served mainly white patient 
populations; and 28 served patients from all 
races and ethnicities.
Eighty-four percent of surveyed practices 
reported seeing sickle cell patients. Only seven 
practices had a sickle cell specialist on staff; 
however, another 71 said there was a sickle 
cell specialist within a one-hour drive. This 
leaves 16 providers and their patients lacking 
practical access to a sickle cell specialist (See 
Figure 1). A large majority of respondents 
reported ease in making specialist referrals for 
their sickle cell patients. 
Figure 1. Access to Sickle Cell Specialists
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Provider Access to Sickle Cell Educational Materials
Survey respondents were asked whether they had educational literature available for sickle cell patients and their families. 
While almost half of the practices reported having general materials on SCD, only about one-fourth had literature on 
appropriate immunizations, and even fewer had literature on TCD (9 percent) and hydroxyurea (10 percent) (See Table 
1). Over half of the respondents reported not having the information they need to appropriately prescribe TCD and 
hydroxyurea for sickle cell patients; almost one-third said they did not have enough information to appropriately prescribe 
immunizations for sickle cell patients. Over one-third of respondents revealed that they do not talk to sickle cell patients 
about immunizations, TCD, and hydroxyurea, nor do they give out materials on the topics. However, almost 60 percent of 
respondents indicated that they, their office, or their patients could use more information on these subjects.
This project is supported by Cooperative Agreement 5U50DD001010 from the Centers for Disease Control and Prevention. Its 
contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.
Discussion
Most pediatric and primary care practices taking part in the survey refer their patients with SCD to specialists. They tend 
to rely on those specialists to manage all aspects of sickle cell care, not keeping educational materials on hand and only 
seeking them out as needed. This is likely a reflection of the small number of providers surveyed who have patients with 
SCD and their perception of having specialists within a one hour drive. Nevertheless, RuSH findings indicate that primary 
care providers, particularly in counties of high sickle cell prevalence, should be on alert for and prepared to interact with, 
advise, and provide optimal care to sickle cell patients. Primary care practitioners serving sickle cell patients should be in 
regular consultation with a hematologist. Additionally, pediatricians can play a particularly significant role in recommend-
ing immunizations and other early treatment options to parents of children with SCD. As a result of this survey, and the 
clear need among primary care providers for sickle cell educational materials, the Georgia PHRESH team is now working 
to distribute hard copy educational materials on immunizations, TCD, and hydroxyurea to survey participants so that they 
are better prepared for future interactions with sickle cell patients.
Figure 2. Availability of Sickle Cell Educational Materials for Patients & Families
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